ATE437853T1 - Glucocorticoid-rezeptoren-modulatoren - Google Patents
Glucocorticoid-rezeptoren-modulatorenInfo
- Publication number
- ATE437853T1 ATE437853T1 AT02714910T AT02714910T ATE437853T1 AT E437853 T1 ATE437853 T1 AT E437853T1 AT 02714910 T AT02714910 T AT 02714910T AT 02714910 T AT02714910 T AT 02714910T AT E437853 T1 ATE437853 T1 AT E437853T1
- Authority
- AT
- Austria
- Prior art keywords
- glucocorticoid receptors
- receptors modulators
- modulators
- diabetes
- mammal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78363601A | 2001-02-14 | 2001-02-14 | |
US10/072,548 US6583180B2 (en) | 2001-02-14 | 2002-02-08 | Glucocorticoid receptor modulators |
PCT/US2002/004501 WO2002064550A1 (en) | 2001-02-14 | 2002-02-12 | Glucocorticoid receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE437853T1 true ATE437853T1 (de) | 2009-08-15 |
Family
ID=26753481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02714910T ATE437853T1 (de) | 2001-02-14 | 2002-02-12 | Glucocorticoid-rezeptoren-modulatoren |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1363876B1 (de) |
JP (1) | JP4499357B2 (de) |
AT (1) | ATE437853T1 (de) |
CA (1) | CA2438480C (de) |
DE (1) | DE60233111D1 (de) |
DK (1) | DK1363876T3 (de) |
ES (1) | ES2328795T3 (de) |
MX (1) | MXPA03007261A (de) |
WO (1) | WO2002064550A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002336532C1 (en) * | 2001-09-14 | 2008-10-16 | Amgen, Inc | Linked biaryl compounds |
AU2003202216A1 (en) | 2002-01-14 | 2003-07-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
EP1490317A1 (de) | 2002-03-26 | 2004-12-29 | Boehringer Ingelheim Pharmaceuticals Inc. | Glucocorticoid-mimetika, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen, und ihre verwendungen |
DK1490062T3 (da) | 2002-03-26 | 2008-04-28 | Boehringer Ingelheim Pharma | Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf |
US7186864B2 (en) | 2002-05-29 | 2007-03-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
US7074806B2 (en) | 2002-06-06 | 2006-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
US6858627B2 (en) | 2002-08-21 | 2005-02-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
WO2004063163A1 (en) | 2003-01-03 | 2004-07-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
US8097606B2 (en) | 2003-07-23 | 2012-01-17 | Corcept Therapeutics, Inc. | Antiglucocorticoids for the treatment of catatonia |
WO2005040145A1 (en) | 2003-10-16 | 2005-05-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
DE602004011985T2 (de) * | 2003-11-25 | 2009-03-05 | Eli Lilly And Co., Indianapolis | Modulatoren des peroxisomproliferatoraktivierten rezeptors |
JP2008525525A (ja) | 2004-12-27 | 2008-07-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | グルココルチコイドミメティクス、その製法、医薬組成物及び使用 |
JP4926955B2 (ja) * | 2005-05-31 | 2012-05-09 | 興和株式会社 | 光学活性ppar活性化化合物及びその製造中間体の製造法 |
TWI410422B (zh) | 2007-01-15 | 2013-10-01 | Mitsubishi Tanabe Pharma Corp | 縮合四氫喹啉衍生物及其醫藥用途 |
TWI490214B (zh) | 2008-05-30 | 2015-07-01 | 艾德克 上野股份有限公司 | 苯或噻吩衍生物及該等作為vap-1抑制劑之用途 |
AU2014274536B2 (en) * | 2008-05-30 | 2016-07-28 | R-Tech Ueno, Ltd. | Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
CA2769563A1 (en) | 2009-07-31 | 2011-02-10 | Cadila Healthcare Limited | Novel compounds as modulators of glucocorticoid receptors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3763141A (en) * | 1968-05-13 | 1973-10-02 | Eastman Kodak Co | Substituted azobenzene compounds |
US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
JP2873745B2 (ja) * | 1991-04-05 | 1999-03-24 | コニカ株式会社 | ビススチリル化合物及び電子写真感光体 |
IL118974A (en) * | 1995-08-17 | 2001-09-13 | Akzo Nobel Nv | History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them |
JPH1063021A (ja) * | 1996-08-23 | 1998-03-06 | Ricoh Co Ltd | 電子写真感光体 |
EP0948570A1 (de) * | 1996-11-27 | 1999-10-13 | Eastman Chemical Company | Verfahren zur herstellung von lichtabsorbierenden polymerzusammensetzungen |
US5929058A (en) * | 1996-12-24 | 1999-07-27 | Zymogenetics, Inc. | Treatment agents and methods for treating type II diabetes and symptoms of type II diabetes |
AU2009799A (en) * | 1997-12-24 | 1999-07-19 | Ortho-Mcneil Pharmaceutical, Inc. | 4-(aryl(piperidin-4-yl)) aminobenzamides which bind to the delta-opioid receptor |
KR20010052431A (ko) * | 1998-06-08 | 2001-06-25 | 오테스코그 페르 | 당뇨병 치료제 |
US6166013A (en) * | 1998-07-30 | 2000-12-26 | Abbott Laboratories | Glucocortiocoid-selective agents |
AU2002303078B2 (en) * | 2001-01-22 | 2007-08-30 | Memory Pharmaceuticals Corporation | Aniline derivatives useful as phosphodiesterase 4 inhibitors |
-
2002
- 2002-02-12 DE DE60233111T patent/DE60233111D1/de not_active Expired - Lifetime
- 2002-02-12 MX MXPA03007261A patent/MXPA03007261A/es unknown
- 2002-02-12 JP JP2002564483A patent/JP4499357B2/ja not_active Expired - Fee Related
- 2002-02-12 WO PCT/US2002/004501 patent/WO2002064550A1/en active Application Filing
- 2002-02-12 AT AT02714910T patent/ATE437853T1/de not_active IP Right Cessation
- 2002-02-12 EP EP02714910A patent/EP1363876B1/de not_active Expired - Lifetime
- 2002-02-12 ES ES02714910T patent/ES2328795T3/es not_active Expired - Lifetime
- 2002-02-12 DK DK02714910T patent/DK1363876T3/da active
- 2002-02-12 CA CA2438480A patent/CA2438480C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE60233111D1 (de) | 2009-09-10 |
DK1363876T3 (da) | 2009-11-30 |
WO2002064550A1 (en) | 2002-08-22 |
CA2438480A1 (en) | 2002-08-22 |
EP1363876B1 (de) | 2009-07-29 |
EP1363876A1 (de) | 2003-11-26 |
MXPA03007261A (es) | 2006-03-09 |
WO2002064550A8 (en) | 2002-11-14 |
JP2005510450A (ja) | 2005-04-21 |
ES2328795T3 (es) | 2009-11-18 |
JP4499357B2 (ja) | 2010-07-07 |
CA2438480C (en) | 2011-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60233111D1 (de) | Glucocorticoid-rezeptoren-modulatoren | |
ATE324371T1 (de) | N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten | |
DE602004011358D1 (de) | (4-hydroxyphenyl)-1h-indol-3-carbaldehydoxim-derivative als östrogenagentien | |
ECSP045133A (es) | Benzoxazoles sustituidos y análogos como agentes estrogenicos | |
BRPI0417717A (pt) | composto, composição farmacêutica, e, uso de um composto | |
AU2003228283A1 (en) | Quinazolinone modulators of nuclear receptors | |
DE60335869D1 (de) | 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren | |
DK1076644T3 (da) | N-Substituerede aminotetraliner som ligander for neutopeptid Y Y5-receptoren, der er nyttig til behandling af fedme og andre lidelser | |
ATE470662T1 (de) | Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor | |
NO20020823D0 (no) | Heterosykliske forbindelser og deres anvendelse som metabotrofisk glutamatreseptor-antagonister | |
NO20052529L (no) | Forbindelse og sammensetning, og anvendelse av samme | |
NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes | |
NO20055516L (no) | Kannabinoidreceptorligander og anvendelser derav | |
AU2002367060A1 (en) | Heterocyclic modulators of nuclear receptors | |
BR0215042A (pt) | fenil-naftalenos substituìdos como agentes estrogênicos | |
BR0010215A (pt) | Derivados de indolina como antagonistas de progesterona | |
DE69820632D1 (de) | 2-phenyl-substituierte 1-(n-phenylaminoalkyl)-piperazin-derivate | |
NO20071922L (no) | Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler | |
DE60126652D1 (de) | Indolderivate | |
ATE416157T1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
DK1063995T3 (da) | Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator | |
YU75601A (sh) | Postupak za pripremanje modulatora nesteroidnih glukokortikoidnih receptora | |
BR0317708A (pt) | Composto, composição farmacêutica, e, uso de um composto | |
DK1379508T3 (da) | N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |